汉防己甲素对先天性膈疝大鼠的保护作用

摘要
图/表
参考文献(22)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (1498 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的：探讨汉防己甲素（TET）产前干预对先天性膈疝（CDH）大鼠的保护作用及机制。方法：将妊娠Sprague-Dawley大鼠随机分为对照组、除草醚组与TET治疗组。后两组孕 9.5 d 时采用除草醚灌胃法建立 CDH 大鼠模型；治疗组自孕18.5 d 起给予 TET 灌胃（每日30 mg/kg，连续3 d）；21 d 对部分孕鼠行剖腹并抽取羊水，观察胎鼠膈疝形成情况。采用 ELISA 法、免疫组化染色法检测羊水和胎肺中 TNF-α 的表达情况。余孕鼠自然分娩，观察各组仔鼠出生后情况。结果：除草醚组胎鼠无论有无膈疝形成均存在肺发育不良，肺及羊水中 TNF-α 的表达均明显升高；TET治疗组胎鼠巨大膈疝的发生率低于除草醚组，肺与羊水中 TNF-α的含量明显较除草醚组少（P＜0.01）。在自然分娩的仔鼠中，TET治疗组仔鼠的 24 h存活率明显高于除草醚组（P＜0.01）。结论：产前应用 TET 能降低CDH大鼠模型胎肺与羊水中 TNF-α 的含量，改善因除草醚诱导的胎鼠肺发育不良，减少巨大膈疝的发生，提高仔鼠的存活率。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	吉毅
	刘文英
	陈思源
	王学军
	杨纲
	徐冰
	曹李明

关键词 ：先天性膈疝, 汉防己甲素, 产前干预, 肺发育不良, 大鼠

Abstract：OBJECTIVE: To study the protective effect of the prenatal use of tetrandrine (TET) against congenital diaphragmatic hernia (CDH) in rats and possible mechanisms. METHODS: Pregnant female Sprague-Dawley rats were randomly divided into 3 groups: control, nitrofen and TET treatment. The later two groups were administered with nitrofen by gavage on day 9.5 of gestation. On day 18.5 of gestation, TET (30 mg/kg) was given by gavage (once a day, for three days) in the TET treatment group. On day 21 of gestation, parts of pregnant rats were delivered by cesarean section and amniotic fluid was collected. The fetal rats were examined for a diaphragmatic hernia. Lung histologic evaluations with microscope and immunohistochemistry staining of TNF-α were performed. TNF-α in amniotic fluid was detected using ELISA. The remaining pregnant rats were allowed to deliver spontaneously at term. The survival of pup rats was observed until 24 hrs of age.ResultsIn the nitrofen group, significant lung hypoplasia was presented not only in fetuses with CDH but also in those without CDH. Stronger expression of TNF-α was observed in fetal lungs and amniotic fluid in the nitrofen group, even when CDH was absent. The TET treatment group showed improved lung development compared with the nitrofen group. The incidence of large diaphragmatic hernia in the TET treatment group was lower than that in the nitrofen group (P<0.05), and the expression of TNF-α in fetal lungs and amniotic fluid in the TET treatment group was also lower than in the nitrofen group (P<0.01). The 24-hr survival rate of pup rats in the TET group was higher than that in the ntrofen group (P<0.01). CONCLUSIONS: Prenatal use of TET can improve nitrofen-induced pulmonary hypoplasia, decrease the incidence of large diaphragmatic hernia and increase the survival rate of pup rats, possibly through a reduction in the production of TNF-α in fetal lungs and amniotic fluid in rats with CDH.

Key words： Congenital diaphragmatic hernia Tetrandrine Prenatal therapy Pulmonary hypoplasia Rats

PACS:

R-33

引用本文:

吉毅,刘文英,陈思源等. 汉防己甲素对先天性膈疝大鼠的保护作用[J]. 中国当代儿科杂志, 2011, 13(5): 401-405.

JI Yi,LIU Wen-Ying,CHEN Si-Yuan et al. Protective effects of tetrandrine against congenital diaphragmatic hernia in rats[J]. CJCP, 2011, 13(5): 401-405.

链接本文:

http://www.zgddek.com/CN/ 或 http://www.zgddek.com/CN/Y2011/V13/I5/401

	［1］Stege G, Fenton A, Jaffray B. Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia［J］. Pediatrics, 2004, 113(4): 917.
	［2］Brownlee EM, Howatson AG, Davis CF, Sabharwal AJ. The hidden mortality of congenital diaphragmatic hernia: a 20-year review［J］. J Pediatr Surg, 2009, 44(2): 317-320.
	［3］Lin H, Wang Y, Xiong Z, Tang Y, Liu W. Effect of antenatal tetrandrine administration on endothelin-1 and epidermal growth factor levels in the lungs of rats with experimental diaphragmatic hernia［J］. J Pediatr Surg, 2007, 42(10): 1644-1651.
	［4］Xu C, Liu W, Chen Z, Wang Y, Xiong Z, Ji Y. Effect of prenatal tetrandrine administration on transforming growth factor-beta 1 level in the lung of nitrofeninduced congenital diaphragmatic hernia rat model［J］. J Pediatr Surg, 2009, 44(8): 1611-1620.
	［5］Harrison MR, Keller RL, Hawgood SB, Kitterman JA, Sandberg PL, Farmer DL, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia［J］. N Engl J Med, 2003, 349(20): 1916-1924.
	［6］Boucherat O, Benachi A, Chailley-Heu B, Franco-Montoya ML, Elie C, Martinovic J, et al. Surfactant maturation is not delayed in human fetuses with diaphragmatic hernia［J］. PLoS Med, 2007, 4(7): e237.
	［7］Clugston RD, Zhang W, Greer JJ. Gene expression in the developing diaphragm: significance for congenital diaphragmatic hernia［J］. Am J Physiol Lung Cell Mol Physiol, 2008, 294(4): L665-L675.
	［8］Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families［J］. N Engl J Med, 1996, 334(26): 1717-1725.
	［9］Vayrynen O, Glumoff V, Hallman M. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung［J］. Am J Physiol Lung Cell Mol Physiol, 2002, 282(4): L803-L810.
	［10］Gitto E, Reiter RJ, Sabatino G, Buonocore G, Romeo C, Gitto P, et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment［J］. J Pineal Res, 2005, 39(3): 287-293.
	［11］Mahieu LM, De Dooy JJ, Ieven MM, Bridts CH, Stevens WJ. Increased levels of tumor necrosis factor-alpha and decreased levels of interleukin-12 p70 in tracheal aspirates, within 2 hrs after birth, are associated with mortality among ventilated preterm infants［J］. Pediatr Crit Care Med, 2005, 6(6): 682-689.
	［12］Montedonico S, Sugimoto K, Felle P, Bannigan J, Puri P. Prenatal treatment with retinoic acid promotes pulmonary alveologenesis in the nitrofen model of congenital diaphragmatic hernia［J］. J Pediatr Surg, 2008, 43(3): 500-507.
	［13］Stinchcombe SV, Maden M. Retinoic acid induced alveolar regeneration: critical differences in strain sensitivity［J］. Am J Respir Cell Mol Biol, 2008, 38(2): 185-191.
	［14］Thébaud B, Tibboel D, Rambaud C, Mercier JC, Bourbon JR, Dinh-Xuan AT, et al. Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats［J］. Am J Physiol, 1999, 277(2 Pt 1): L423-L429.
	［15］Lally KP, Bagolan P, Hosie S, Lally PA, Stewart M, Cotton CM, et al. Corticosteroids for fetuses with congenital diaphragmatic hernia: can we show benefit?［J］. J Pediatr Surg, 2006, 41(4): 668-674.
	［16］Xie QM, Tang HF, Chen JQ, Bian RL. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases［J］. Acta Pharmacol Sin, 2002, 23(12): 1107-1113.
	［17］Lin TY, Tseng SH, Li SJ, Chen JC, Shieh JS, Chen Y. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia［J］. J Trauma, 2009, 66(2): 411-417.
	［18］Oh SH, Lee BH. Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release［J］. Biochem Pharmacol, 2003, 66(5): 725-731.
	［19］吉毅, 刘文英, 徐畅, 王元祥，覃道锐，罗淼. 汉防己甲素对先天性膈疝大鼠模型胎仔肺发育不良的影响及意义［J］. 中华小儿外科杂志，2010，31(2)：123-127.
	［20］Beckman DL, Cummings JJ, Katwa LC, Whitehurst ME. Can maternal vitamin e supplementation prevent lung hypoplasia in the nitrofen-induced rat model of congenital diaphragmatic hernia?［J］. Pediatr Res, 2005, 57(3): 392-395.
	［21］Teshima R, Nakamura R, Nakajima O, Hachisuka, Sawada J. Effect of two nitrogenous diphenyl ether pesticides on mast cell activation［J］. Toxicol Lett, 2004, 150(3): 277-283.
	［22］蔡栩栩，吴文斌，杜悦，刘春峰，张红，卢岩，等. TNF2α 和 IκBα 在内毒素致新生大鼠肺出血中的作用研究［J］. 中国当代儿科杂志，2003，5(4): 301-305.